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Retinitis pigmentosa (RP) is a group of inherited diseases that damage rod and cone cells located in 
human retina. A nonsense mutation R677X has been identified in RP1 gene which not only causes 
mRNA degradation but also results in truncated protein production leading towards visual disparity in 
humans. Secondary structure of RP1 gene was determined in order to elucidate the structural changes 
conferred due to nonsense mutation R677X. The structural differences among non mutated and 
mutated RP1 gene range from 23 to 43%. Similarly, the truncated protein also resulted in the loss of 
certain functional as well as active sites which were identified by predicting motifs. A detailed 
comparison between non mutated and mutated RP1 gene revealed the significance of R677X mutation 
causing significant structural (helix, turn, sheet and coil) as well as functional loss. Four domains of 
RP1 gene were predicted using ModWeb and SWISS – MODEL Comparative Modeling Server. The 3D 
structures of the domains were determined based upon the crystal structure of the homologous 
templates. The 3D structures were then verified using PROCHECK protein structure validation and 
verification tool. The quality of the structures obtained was good. This is also useful for future work for 
annotating the functions of protein using their structures.  
 





Retinitis pigmentosa (RP) is a group of inherited diseases 
that smash up the light-sensitive rods and cones posi-
tioned in the retina. Rods, which are endowed with side 
(peripheral) and night vision, are exaggerated more than 
the cones that provide colour and clear central vision. RP 
first affects the rods in the human eye. As the rods are 
damaged, vision in low light decreases and peripheral 
vision constricts (Riazuddin et al., 2005). Further pro-
gression of the disease then affects the cones, leading to 
central vision loss and often leads towards blindness in 
humans (Liu et al., 2002). Typical symptoms include night 
blindness, progressive visual field constriction and 
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Abbreviations: adRP, Autosomal dominant retinitis 
pigmentosa; RP, retinitis pigmentosa. 
Approximately one out of 3,000 to 4,000 individuals is 
affected with RP (Haim 2002). RP can be passed on by 
all types of inheritance, 20 - 25% is autosomal dominant, 
15 to 20% is autosomal recessive and 5 to10% is X 
linked, while the remaining 45 to 50% is found in patients 
without any known affected relatives (Guillonneau et al., 
1999). RP is most commonly found in isolation, but it can 
be associated with systemic disease. The most common 
systemic association is hearing loss (up to 30% of 
patients). Many of these patients are diagnosed with 
Usher syndrome. Other systemic conditions also demon-
strate retinal changes identical to RP (Riazuddin et al., 
2005).  
Retinitis pigmentosa can result from mutations in more 
than 45 genes (Hartong et al., 2006). RP1 is the fourth 
identified gene causing adRP. The other three include 
rhodopsin, RSD-peripherin and NRL (Guillonneau et al., 
1999). All the introns and exons of RP1 gene were 
confirmed by sequencing the cDNA products of RT- PCR 
using human retinal mRNA as a template (Guillonneau et 






R677X has been identified which causes degradation of 
mRNA and leads towards the production of truncated 
protein lacking ~70% of its original length (Guillonneau et 
al., 1999; Schwartz et al., 2003).  
In this study, a detailed analysis of RP1 gene was carried 
out using different bioinformatics online tools. PSIPRED 
method (Jones, 1999) was used for predicting secondary 
structure of Retinitis pigmentosa 1 protein. Secondary 
structure enabled us to monitor in detail structural res-
ponses due to mutations, thus the entire work revealed 
the impact of missense mutation not only on the structure 
of the protein encoded by RP1 gene but also on its 
function.  
Motifs, which highlighted the presence of different func-
tional as well as active sites within the RP1 gene were 
predicted using PROSITE method (Hulo et al., 2004). 
Domains were predicted using SWISS-MODEL compa-
rative modeling method (Arnold et al., 2006) and 3D models 
of the domains were built using ModWeb Comparative 
Modeling server (Pieper et al., 2009). The 3D structures 
of the domains were determined based upon the crystal 
structure of the homologous templates. The 3D structures 
were then verified using PROCHECK protein structure 
validation and verification tool (Laskowski et al., 1993). 
The quality of the structures obtained was good. This is 
also useful for future work for annotating the functions of 
protein using their structures.  
 
 
MATERIALS AND METHODS 
 
Retrieval of gene sequence 
 
The amino acid sequence of RP1 (ref: NP_006260.1) gene was 
obtained from the National Center for Biotechnology Information 
(NCBI) (http://www.ncbi.nlm.nih.gov). Different online Bioinformatics 
tools were used for the analysis and structure prediction of RP1 gene.  
 
 
Secondary structure prediction 
 
Methods predicting protein secondary structure improved sub-
stantially in the 1990s through the use of evolutionary information 
taken from the divergence of proteins in the same structural family. 
Secondary structure predictions are increasingly becoming the work 
horse for numerous methods aimed at predicting protein structure 
and function. PROF, PSIPRED and SSpro are the three very well 
known methods for predicting secondary structure with the 
accuracy rate of 77.0, 76.7 and 76.3%, respectively. However, such 
methods allow monitoring in detail, structural responses to muta-
tions. Further more, if the function/structure of protein A is known 
and to infer whether B shares this function/structure, a similarity in 
the local secondary structure may help substantially (Rost, 2001).   
In this study, PSIPRED method (Jones, 1999) was used for 
predicting secondary structure of Retinitis pigmentosa 1 protein 
and further certain predictions were made in order to elucidate the 





Function is anything that occurs to or through  a  protein.  Predicting  




function of a protein is done using either structure or sequence and 
it is based upon homology that is, similar sequence similar struc-
ture, similar sequences similar function. But still doubts occur for 
the second fact similar sequences similar function. In this study 
PROSITE method (Hulo et al., 2004) was used for predicting motifs 





Comparative modelling is predicting 3D structure of protein using 
sequence. Let proteins A and B have homologous 3D structures, 
the coordinates of protein A are known than the structure of protein 
B is modelled using protein A.  
Three-dimensional (3D) protein structures are of great interest for 
the rational design of many different types of biological experi-
ments, such as site-directed mutagenesis or structure-based 
discovery of specific inhibitors. However, the number of structurally 
characterized proteins is small as compared with the number of 
known protein sequences. Various computational methods for 
modeling 3D structures of proteins have been developed to 
overcome this limitation. Homology modeling has proven to be the 
method of choice to generate a reliable 3D model of a protein from 
its amino acid sequence (Arnold et al., 2006).  
In this study, SWISS-MODEL (Arnold et al., 2006) and ModWeb 
Comparative Modeling methods (Pieper et al., 2009) were used for 
3D model building. It enabled us to identify not only the two already 
existing domains of the Retinitis pigmentosa 1 protein but also 
three new domains.  The 3D structures were then verified using 
PROCHECK protein structure validation and verification tool 
(Laskowski et al., 1993). Identification of these domains is useful 
for future work determining the crystal structure of the domains and 





Secondary structure prediction 
 
The secondary structure of Retinitis pigmentosa 1 protein 
was predicted in order to monitor in detail structural res-
ponses due to mutation(s).The residual comparison 
based upon secondary structure prediction enabled us to 
predict the extent of structural loss due to nonsense 
mutation R677X. The residual comparison mark the point 
of structural differences in non mutated and mutated RP1 





Motif prediction is useful in function annotation by finding 
a motif or a pattern in functionally characterized family 
and searching for the same motif or pattern in a new 
protein and finally transfer function annotation to the new 
protein. The nonsense mutation R677X which lead to-
wards the production of truncated protein lacking ~70% of 
its original length (Guillonneau et al., 1999; Schwartz et 
al., 2003) also results in the loss of certain motifs in 
Retinitis pigmentosa 1 protein a comparison  of  which  is  
 















Coils converting in beta sheet 
111 K Coil Sheet 
154 R Coil Sheet 
266,267 HM Coil Sheet 
279 S Coil Sheet 
387,388 FS Coil Sheet 
430,431 VD Coil Sheet 
470 V Coil Sheet 
493 E Coil Sheet 
509 S Coil Sheet 
613 to 616 THFS Coil Sheet 
628 E Coil Sheet 
657 L Coil Sheet 
Beta sheets converting into coils 
90,91 HS Sheet Coil 
107 S Sheet Coil 
131 R Sheet Coil 
134 S Sheet Coil 
309 to 311 NLP Sheet Coil 
345 E Sheet Coil 
354 S Sheet Coil 
391 V Sheet Coil 
436 Q Sheet Coil 
445 to 447 RFY Sheet Coil 
463 to 465 VIG Sheet Coil 
505 C Sheet Coil 
588 N Sheet Coil 
Helices converting into coils 
100 D Helix Coil 
239,240 LP Helix Coil 
367 M Helix Coil 
454 L Helix Coil 
462 S Helix Coil 
624,625 KN Helix Coil 
660 N Helix Coil 
666 S Helix Coil 
Coils converting into helices 
296,297 PE Coil Helix 
361-363 NDE Coil Helix 
380 L Coil Helix 
428,429 AT Coil Helix 
432 T Coil Helix 
491,492 SG Coil Helix 
 














Beta sheets converting into helices 
262,263 KI Sheet Helix 
412,413 MT Sheet Helix 
435 I Sheet Helix 
443,444 KH Sheet Helix 
486 to 488 SEE Sheet Helix 
575 I Sheet Helix 
587 D Sheet Helix 
590 T Sheet Helix 
648 to 651 EFAQ Sheet Helix 
322 S Helix Sheet 
457 to 461 VRQKK Helix Sheet 
482 Q Helix Sheet 
549 to 552 VIEI Helix Sheet 
Probability 
Determination 
   
No. of  Coils converting into Beta sheets 12 
No. of  Beta sheets converting into Coils 14 
No. of  Helices converting into Coils 8 
No. of  Coils converting into Helices 6 
No. of  Helices converting into Beta sheets 4 
No. of Beta sheets converting into Helices 9 
Probability of Coils converting into Beta sheets (12/53) = 0.226 ~ 0.23  
Probability of Coils converting into Helices (6/53) = 0.11 
Probability of Helices converting into Coils (8/53) = 0.15 
Probability of Helices converting into Beta sheets (4/53) = 0.075 ~ 0.08 
Probability of Beta sheets converting into Coils (14/53) = 0.26 









Building a homology model comprises four main steps: 
(1) Identification of structural template(s), (2) alignment of 
target sequence and template structure(s), (3) model 
building and (4) model quality evaluation. These steps 
can be repeated until a satisfying modeling result is 
achieved. Each of the four steps require specialized 
software as well as access to up-to-date protein sequen-
ce and structure databases (Arnold et al., 2006). 
The two already existing Doublecortin domains were 
identified using SWISS-MODEL comparative modeling 
server. The two 3D structures of the doublecortin ob-
tained by SWISS-MODEL comparative modeling server 
have been reported earlier. The ModWeb Comparative 
Modeling methods (Pieper et al., 2009) were further used 
for predicting 3D structures of other domains of RP1 
gene. The 3D structures of three new domains were 
identified and have been shown in Figures 1 - 3. 
The predicted 3D models of three new domains (Figures 
1–3) have not been reported earlier and hence are the 
theoretical models of RP1 gene. A brief description of the 
three new domains of RP1 gene has been shown in 
Table 3. 
The 3D models of the domains were built based upon 
the templates that show maximum sequence identity with 
the target region. Hence three models were predicted 
and their coordinates file was obtained using ModWeb 
Comparative Modeling methods (Pieper et al., 2009). The 
models are theoretical models and are not experimentally 
verified. The quality of the predicted models was further 
verified using PROCHECK protein structure validation and 
verification tool (Laskowski et al., 1993). The validation of 
the models was carried out using Ramachandran plot 
calculations computed with PROCHECK. The phi and psi 
distributions of the Ramachandran plots of non-glycine, 
non-proline residues is summarized in Tables 4 to  6  and  
 




Table 2. Comparison of predicted motifs in mutated and non mutated RP1 gene. 
 
Predicted site 
No. of predicted 
motif (mutated) 
No. of predicted 
motifs (non mutated) 
N-glycosylation site  9 28 
cAMP- and cGMP-dependent protein kinase phosphorylation site.  4 9 
Protein kinase C phosphorylation site.  16 42 
Protein Casein kinase II phosphorylation site. 12 52 
Tyrosine kinase phosphorylation site. 0 3 
N-myristoylation site  5 21 
Amidation site  2 3 
Cell attachment sequence 0 2 
Leucine zipper pattern  0 1 




Table 3. Details of the three new domains of RP1 gene. 
 
Domain Target Region Template Template Region Sequence identity E- value 
I 1624 to 1677 3ec1A 172 to 221 40 % 0.489 
II 1553 to 1845 1k90A 394 to 696 22% 0.320 




Table 4.  Ramachandran plot calculations on 3D model of predicted domain I of RP1 gene.  
 
Parameter No. of residue % 
Most favored regions [A,B,L] 39 84.8 
Additionally allowed regions [a,b,l,p] 6 13.0 
Generously  allowed regions [~a,~b,~l,~p] 0 0.0 
Disallowed regions [XX] 1 2.2 
Non glycine, non proline residues 46 100 
End residues (excl. glycine, proline) 1 - 
Glycine residues 4 - 
Proline residues 3 - 




Table 5. Ramachandran plot calculations on 3D model of predicted domain II of RP1 gene. 
 
Parameter No. of residue % 
Most favored regions [A,B,L] 220 85.3 
Additionally allowed regions [a,b,l,p] 31 12.0 
Generously  allowed regions [~a,~b,~l,~p] 4 1.6 
Disallowed regions [XX] 3 1.2 
Non glycine, non proline residues 258 100 
End residues (excl. glycine, proline) 2 - 
Glycine residues 17 - 
Proline residues 16 - 
Total no. of residues 293 - 
 




Table 6. Ramachandran plot calculations on 3D model of predicted domain III of RP1 
gene.  
 
Parameter No. of residue % 
Most favored regions [A,B,L] 127 85.8 
Additionally allowed regions [a,b,l,p] 16 10.8 
Generously  allowed regions [~a,~b,~l,~p] 3 2.0 
Disallowed regions [XX] 2 1.4 
Non glycine, non proline residues 148 100 
End residues (excl. glycine, proline) 2 - 
Glycine residues 7 - 
Proline residues 3 - 






Figure 1. Predicted 3D structure of 






Figure 2. Predicted 3D structure 




Figures 4 to 6. 
The percentage of residues within the most favoured 
regions is 84.8, additionally allowed regions is 13.0 and  
generously allowed regions is 0.0 therefore more than 
90% residues lie within the allowed regions and hence 
they form a good quality model. The percentage of 
residues within the most favoured regions is 85.3, addi-
tionally allowed regions is 12.0 and generously allowed 
regions is 1.6 therefore more than 90% residues lie within  
 
 
Figure 3. Predicted 3D 





the allowed regions and hence they form  a  good  quality  
model. The percentage of residues within the most 
favored regions is 85.8, additionally allowed regions is 
10.8 and generously allowed regions is 2.0 therefore 
more than 90% residues lie within the allowed regions 





The comparison clearly supports the fact that missense 
mutation R677X causes degradation of mRNA and leads 
towards the production of truncated protein lacking ~70% 
of its original length (Guillonneau et al., 1999; Schwartz 
et al., 2003). There exists a loss of 1518 amino acids 
which not only reduces the important functional sites 
within RP1 gene but also results in its improper func-
tioning. The detailed residual comparison showed that 
23% coils converted into beta sheets and 11% of them 
converted to helices. Fifteen percent (15%) helices 
converted into coils and 8% converted into beta sheets. 
Twenty six percent (26%) beta sheets converted into 
coils and 17% into helices. So  there  exists  34%  loss  in  
 












Figure 5. Ramachandran plot for predicted domain II of RP1 gene. 
 










coils, 23% loss in helices and 43% loss in beta sheets in 
RP1 gene. The nonsense mutation R677X which leads 
towards the production of truncated protein lacking ~70% 
of its original length (Guillonneau et al., 1999; Schwartz 
et al., 2003) also results in structural loss of about 23 to 
43% in RP1 gene. Therefore the detailed residual com-
parison highlighted the structural changes due to 
nonsense mutation R677X. 
The total number of N-glycosylation sites in wild type 
RP1 gene were 28, cAMP- and cGMP-dependent protein 
kinase phosphorylation sites 9, protein kinase C phos-
phorylation sites 42, protein casein kinase II phos-
phorylation sites 53, tyrosine kinase phosphorylation sites 
3, N-myristoylation sites 21, amidation sites 3, cell 
attachment sequences 2, leucine zipper pattern 1 and 
nucleoside diphosphate kinases active site 1. The total 
no. of N-glycosylation sites in mutant type RP1 gene 
were 9, cAMP- and cGMP-dependent protein kinase 
phosphorylation sites 4, protein kinase C phosphorylation 
sites 16, protein casein kinase II phosphorylation sites 
12, no tyrosine kinase phosphorylation site, N-myris-
toylation sites 5, amidation sites 2, no cell attachment 
sequence, no leucine zipper pattern 1 and no nucleoside 
diphosphate kinases active site. There exists significant 
loss in N-glycosylation, cAMP- and cGMP-dependent 
protein kinase C phosphorylation, protein casein kinase II 
phosphorylation and N-myristoylation sites where as 
tyrosine kinase phosphorylation, cell attachment, leucine 
zipper and nucleoside diphosphate kinase active sites 
were completely lost due to missense mutation R677X.  
The 3D structures of the domains were (Figures 1 – 3) 
determined based upon the crystal structure of the 
homologous templates and were then verified using 
PROCHECK protein structure validation and verification 
tool (Laskowski et al., 1993). The quality of the structures 
obtained was good. This is also useful for future work for 





Arnold K, Lorenza B, Ju¨ rgen K, Torsten S (2006). The SWISS-MODEL 
workspace: a web-based environment for protein structure homology 
modelling. Bioinformatics, 22: 195-201. 
Daiger SP, Bowne SJ, Sullivan LS  (2007).  Perspective  on  genes  and 
 




mutations causing retinitis pigmentosa. Arch. Ophthalmol. 125: 151-
158.  
Guillonneau X, Natik IP, Michael D, Christine AK, Artur VC, Samuel GJ, 
Debora BF (1999). A nonsense mutation in novel gene is associated 
with retinitis pigmentosa in a family linked to the RP1 locus. Hum. 
Mol. Genet. 8: 1541-1546. 
Haim M (2002). Epidemiology of retinitis pigmentosa in Denmark. Acta 
Ophthalmol. Scand. 233: 1-34.  
Hartong DT, Berson EL, Dryja TP (2006). Retinitis pigmentosa. Lancet, 
368: 1795-809.  
Hulo N, Christian JAS, Virginie LS, Petra SLG, Lorenza B, Alexandre G, 
Edouard D CPB, Amos B (2004). Recent improvements to the 
PROSITE database. Nucleic Acids Res. 32: D134-D137. 
Jones DT (1999). Protein secondary structure prediction based on 
position-specific scoring matrices. J. Mol. Biol. 292: 195-202.  
Laskowski RA, Malcolm WM, David SM, Janet MT (1993). PROCHECK: 
a program to check the stereochemical quality of protein structures. 
J. Appl. Cryst. 26: 283-291. 
Liu Q, Jie Z, Stephen PD, Debora BF, John RH, Julie ES, Lori SS, Jian 
Z, Ann HM, Eric AP (2002). Identification and subcellular localization 






















































Pieper U, Narayanan E, Ben MW, David E, Libusha K, David TB, 
Hannah C, Parminder M, Rachel K, Marc AM, Fred PD, Andrej S 
(2009). MODBASE, a database of annotated comparative protein 
structure models and associated resources. Nucleic Acids Res. 37: 
D347-D354. 
Riazuddin SA, Fariha Z, Qingjiong Z, Yuri VS, Zaheeruddin AQ, Tayyab 
H, Rafael C, Sheikh R, Paul AS, Fielding JH (2005). Autosomal 
recessive retinitis pigmentosa is associated with mutations in RP1 in 
three consanguineous Pakistani families. Invest. Ophthalmol. Vis Sci. 
46: 2264-2270. 
Rost B (2001). Protein secondary structure prediction continues to rise. 
J. Struct. Biol. 134: 204-18. 
Schwartz SB, Tomas SA, Artur VC, Anand S, Samuel GJ, Edwin MS 
(2003). De Novo Mutation in the RP1 Gene (Arg677ter) Associated 
with Retinitis Pigmentosa. Invest. Ophthalmol. Vis Sci. 44: 3593-
3597. 
 
 
 
